J&J Settles Texas' Risperdal Suit For $158M

Law360, New York (January 19, 2012, 1:07 PM EST) -- A Johnson & Johnson unit will pay $158 million to settle claims by the state of Texas that it illegally marketed antipsychotic drug Risperdal, the company announced Thursday.

The lawsuit sought more than $1 billion in reimbursement and penalties.

“This settlement represents a resolution to claims brought by the state in 2004 for alleged Medicaid overpayment during the years 1994 [to] 2008, and will circumvent potentially lengthy and costly appellate activities,” the unit, Janssen Pharmaceuticals Inc., said in a statement.

A Janssen spokeswoman said the company...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.